CD45RA Antibody, anti-mouse, REAfinity™
RECOMBINANT EXTENDED VALIDATION
Clone:
REA639 | 14.8
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD45RA Antibody, anti-mouse, REAfinity™

Flow cytometry applications
APC
APC-Vio 770
Biotin
FITC
PE
PE-Vio 770
PerCP-Vio 700
Vio Bright B515
VioBlue
Recommended dilution:
1:10
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-109-777, 130-109-730
Description:
Splenocytes from BALB/c mice were stained with CD45RA antibodies or with the corresponding REA Control antibodies (left images) as well as with CD19 antibodies. Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

Application imageView details view details

Application imageView details view details
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
frozen – PFA
Species tested:
mouse
Tissue used:
spleen
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-140-142
Testing grade:
Description:
Immunofluorescence analysis of a mouse spleen cryosection fixed with 4% PFA. The section was stained using CD45RA Antibody, anti-mouse, APC (green) for 10 min at room temperature. Nuclei were visualized with Hoechst™ (blue).Scale bar: 30 µm.

Application image
Fixation:
FFPE
Species tested:
mouse
Tissue used:
spleen
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-140-142
Testing grade:
Description:
Immunofluorescence analysis of a formalin-fixed, paraffin embedded (FFPE) mouse spleen. Before staining, antigens were retrieved using heat-induced epitope retrieval (HIER) at pH 9. The section was stained using CD45RA Antibody, anti-mouse, APC (green) for 10 min at room temperature. Nuclei were visualized with Hoechst™ (blue).

Application imageView details view details

Application imageView details view details
Extended validation for CD45RA Antibody, anti-mouse, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA639
14.8
partial

Cells were incubated with an excess of purified unconjugated CD45RA (REA639) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Extended-Validation detailed information image

Flow cytometric comparison of different clones for CD45RA shown as histograms

Specifications for CD45RA Antibody, anti-mouse, REAfinity™
Overview

Clone REA639 recognizes the exon A-dependent epitope CD45RA in mouse, one of eight isoforms of the transmembrane glycoprotein CD45, which is a member of the protein tyrosine phosphatase (PTP) family. CD45RA is expressed highly on B cells, weakly on CD8+ T cells, and nearly on all B cell–lineages but it is not detectable on hematopoietic stem cells or myeloid progenitors.

Additional information: Clone REA639 displays negligible binding to Fc receptors.

Detailed product information

Technical specifications

Clone
REA639
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
CD45RA
Molecular mass of antigen [kDa]
135
Distribution of antigen
T cells, B cells
Entrez Gene ID
RRID
AB_2658327, AB_2658322, AB_2905026, AB_2658323, AB_2784219, AB_2658330, AB_2658328, AB_2658336, AB_2658326, AB_2658331, AB_2658337, AB_2658329, AB_2658334, AB_2658332, AB_2658333, AB_2658335

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD45RA Antibody, anti-mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD45RA Antibody, anti-mouse, REAfinity™
Publications
  1. Hathcock, K. S. et al. (1992) Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations. J Immunol 148: 19-28
  2. Inoue, T. et al. (1993) Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine. J Immunol 150: 2121-2128